Pharyngitis overview: Difference between revisions

Jump to navigation Jump to search
No edit summary
 
(23 intermediate revisions by the same user not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Pharyngitis}}
{{Pharyngitis}}
{{CMG}}; {{AE}}{{VSKP}}
{{CMG}}; {{AE}}{{VSKP}}{{DYM}}


{{SK}} Sore throat; Group A streptococcal pharyngitis; Bacterial pharyngitis; Viral pharyngitis; Acute pharyngitis; Chronic pharyngitis
{{SK}} Sore throat; Group A streptococcal pharyngitis; Bacterial pharyngitis; Viral pharyngitis; Acute pharyngitis; Chronic pharyngitis
==Overview==
==Overview==
Acute [[pharyngitis]] is typically defined as the triad of [[sore throat]], [[fever]], and pharyngeal [[inflammation]] characterized by [[erythema]] and [[edema]], although [[Exudate|exudates]], [[Vesicle|vesicles]], or [[ulcerations]] may also be present. Pharyngitis is the [[inflammation]] of the [[pharynx]], manifested as a [[sore throat]]. It is a [[pain and nociception|painful]] inflammation of the [[pharynx]] and is colloquially referred to as a sore throat. [[Pharyngitis]] is a common medical problem in the outpatient medical setting, resulting in more than seven million [[pediatric]] visits each year. Most types of pharyngitis are caused by infectious etiologies. The most common cause of pharyngitis is a [[viral infection]]. However, some of the more serious types of [[pharyngitis]] are attributed to bacterial etiologies, such as [[Group A streptococcus|group A-hemolytic Streptococcus]] pyogenes ([[Group A beta-hemolytic streptococci|GAS]]). Complications from [[Group A streptococcal infection|GAS]] pharyngitis include [[rheumatic fever]], [[Abscesses|deep space abscesses]], and [[toxic shock]]. Although most episodes of [[pharyngitis]] are acute in nature, a small percentage becomes [[recurrent]] or chronic. With regards to [[chronic pharyngitis]], [[non-infectious]] etiologies, such as [[Laryngopharyngeal]] [[reflux]] disease|laryngopharyngeal [[reflux]] and periodic [[fever]], [[aphthous ulcers]], pharyngitis, and [[Adenitis|adenitis syndrome]] also need to be considered. Both medical and surgical therapies are effective in managing pharyngitis. First-line medical therapy includes antibiotic therapy. For certain indications, surgical management via [[Tonsillectomy|adenotonsillectomy]] is recommended. [[Tonsillectomy|Adenotonsillectomy]] has been shown to be effective in reducing disease burden and improving disease-specific and global quality of life. Several techniques for [[Tonsillectomy|adenotonsillectomy]] exist, including traditional and [[intracapsular]] [[tonsillectomies]].
A triad of [[sore throat]], [[fever]], and pharyngeal [[inflammation]] marked by [[erythema]] and [[edema]] are usually described as [[acute pharyngitis]], although [[exudates]], [[vesicles]], or [[ulcerations]] may also be present. The inflammation of the [[pharynx]], which presents as a [[sore throat]], is [[pharyngitis]]. It is a [[pain and nociception|painful]] inflammation of the [[pharynx]] and is colloquially referred to as a sore throat. [[Pharyngitis]] is a common medical problem in the outpatient medical setting, resulting in more than seven million [[pediatric]] visits each year. Most types of pharyngitis are caused by infectious etiologies. The most common cause of pharyngitis is a [[viral infection]]. However, some of the more serious types of [[pharyngitis]] are attributed to bacterial etiologies, such as [[Group A streptococcus|group A-hemolytic Streptococcus]] pyogenes ([[Group A beta-hemolytic streptococci|GAS]]). Complications from [[Group A streptococcal infection|GAS]] pharyngitis include [[rheumatic fever]], [[Abscesses|deep space abscesses]], and [[toxic shock]]. Although most episodes of [[pharyngitis]] are acute in nature, a small percentage becomes [[recurrent]] or chronic. With regards to [[chronic pharyngitis]], [[non-infectious]] etiologies, such as [[Laryngopharyngeal]] [[reflux disease]] and periodic [[fever]], [[aphthous ulcers]], pharyngitis, and [[Adenitis|adenitis syndrome]] also need to be considered. Both medical and surgical therapies are effective in managing pharyngitis. Antibiotic treatment requires first-line medical therapy. Surgical management via [[adenotonsillectomy]] is recommended for certain indications. [[Adenotonsillectomy]] has been shown to be effective in reducing the burden of disease and improving the global quality of life and disease-specific. Several procedures, including traditional and [[intracapsular]] [[tonsillectomies]], exist for [[adenotonsillectomy]].


== Historical Perspective ==
== Historical Perspective ==
* [[Sore throat]] was first described in the literature as 'some variants of sore throat' in the year 1879 by R. L. Bowles, M.D., in the British medical journal.
The sore throat was first described in the literature as 'some variants of sore throat' in the year 1879 by R. L. Bowles, M.D., in the British Medical Journal. Later, in 1885, David Newman, M.D., described [[pathology]], symptoms, and treatment of [[pharyngitis]].In 1910, the importance of [[bacteriological]] tests was shown in doubtful cases of pharyngitis. In 1931,   three case reports were described and inferred that chronic [[non-tuberculous]] [[bronchial]] disease such as [[influenza]], [[whooping cough]], and [[measles]] is associated with chronic [[nasopharyngitis]] and also described the importance of conservative treatment in chronic nasopharyngitis.
* Later, David Newman, M.D., described [[pathology]], symptoms, and treatment of [[pharyngitis]] in his lectures at the Glasgow Royal Infirmary, during the winter session of 1885.
* Dr. Donelan illustrated the importance of [[bacteriological]] tests in doubtful cases of [[pharyngitis]].
* In 1931, WM. W. Priddle, B.A., M.D., described three case reports and inferred that chronic [[nontuberculous]] bronchial disease such as [[influenza]], [[whooping cough]], and [[measles]] are associated with chronic [[nasopharyngitis]] and also described the importance of conservative treatment in chronic [[nasopharyngitis]].


== Pathophysiology ==
== Pathophysiology ==
Line 26: Line 23:


== Epidemiology and Demographics ==
== Epidemiology and Demographics ==
[[Pharyngitis]] is one of the most common disorders in adults and children, with more than 10 million [[ambulatory]] visits per year.[[ Viruses]] are the single most common cause of pharyngitis and account for 25% to 45% of all cases. [[Group A streptococcus]] presents in up to 37% of all children presenting with a sore throat to an outpatient clinic or ED and 24% of those presenting at younger than 5 years. [[Group A streptococcus]] is by far the most common [[bacterial]] cause of [[acute pharyngitis]], accounting for approximately 15 to 30 percent of cases in children and 5 to 10 percent of cases in adults. Peak seasons for [[sore throat]] include late winter and early spring.
With more than 10 million outpatient visits per year, [[pharyngitis]] is one of the most common disorders in adults and children. [[Viruses]] are the single most common cause of [[pharyngitis]] and account for 25 percent to 45 percent of all cases. [[Group A streptococcus]] presents in up to 37% of all children presenting with a sore throat to an outpatient clinic or ED and 24% of those presenting at younger than 5 years. [[Group A streptococcus]] is by far the most common [[bacterial]] cause of [[acute pharyngitis]], accounting for approximately 15 to 30 percent of cases in children and 5 to 10 percent of cases in adults. Peak seasons for [[sore throat]] include late winter and early spring.


== Risk Factors ==
== Risk Factors ==
Line 76: Line 73:
|}
|}
=== History and Symptoms ===
=== History and Symptoms ===
[[Pharyngitis]] is a very common inflammatory condition of the pharynx accompanied by a sore throat and occasionally difficulty in swallowing. Other symptoms depends on the etiology such as bacterial or viral.
[[Pharyngitis]] is a very common inflammatory condition of the pharynx accompanied by a sore throat and occasionally difficulty in swallowing. Other symptoms depends on the etiology such as [[bacterial]] or [[viral]].
{| class="wikitable"
{| class="wikitable"
! colspan="2" |Clinical features of acute pharyngitis
! colspan="2" |Clinical features of acute pharyngitis
Line 107: Line 104:


=== Physical Examination ===
=== Physical Examination ===
Patients with [[pharyngitis]] typically have low-grade [[fever]] and pharyngeal [[erythema]], suggestive of viral etiology or [[pharyngeal exudate]] or [[petechia]], suggestive of [[Group A streptococcal infection|GAS]]. Additional signs include enlarged [[edematous]] [[tonsils]], enlarged and/or [[tender]] [[cervical adenopathy]], the [[rash]] that may or may not be present. [[Scarlet fever|Scarlatiniform rash]], which is marked by multiple small red [[papules]] that are widely and diffusely distributed but spare the [[palms]] and [[soles]], is suggestive of [[Group A streptococcal infection|GAS]].
Patients with [[pharyngitis]] typically have low-grade [[fever]] and pharyngeal [[erythema]], suggestive of [[viral]] etiology or [[pharyngeal]] [[exudate]] or [[petechia]], suggestive of [[Group A streptococcal infection|GAS]]. Additional signs include enlarged [[edematous]] [[tonsils]], enlarged and/or [[tender]] [[cervical]] [[adenopathy]], the [[rash]] that may or may not be present. [[Scarlet fever|Scarlatiniform rash]], which is marked by multiple small red [[papules]] that are widely and diffusely distributed but spare the [[palms]] and [[soles]], is suggestive of [[Group A streptococcal infection|GAS]].


'''Centor criteria'''<br>The original Center score uses four signs and symptoms to estimate the probability of acute [[streptococcal]] [[pharyngitis]] in adults with a [[sore throat]] The score was later modified by adding age. It is important to evaluate for a definitive diagnosis to exclude [[Group A streptococcal infection|GAS]] and to avoid unnecessary lab tests and antibiotic use. Centor criteria are a widely used and accepted clinical decision tool in identifying patients for whom neither [[microbiologic]] tests nor [[antimicrobial]] therapy is necessary. The Center score to use for children and adults with a [[sore throat]] to estimate the probability of [[Streptococcus]] pyogenes infection.
'''Centor criteria'''<br>The original Center score uses four signs and symptoms to estimate the probability of acute [[streptococcal]] [[pharyngitis]] in adults with a [[sore throat]] The score was later modified by adding age. It is important to evaluate for a definitive diagnosis to exclude [[Group A streptococcal infection|GAS]] and to avoid unnecessary lab tests and antibiotic use. Centor criteria are a widely used and accepted clinical decision tool in identifying patients for whom neither [[microbiologic]] tests nor [[antimicrobial]] therapy is necessary. The Center score to use for children and adults with a [[sore throat]] to estimate the probability of [[Streptococcus]] pyogenes infection.
Line 118: Line 115:
| align="center" |'''Points'''
| align="center" |'''Points'''
|'''Total score'''
|'''Total score'''
| align="center" |'''Chance of streptococcal infection in community'''  
| align="center" |'''Chance of [[streptococcal]] infection in community'''  
'''with usual levels of infection, %'''
'''with usual levels of infection, %'''
| align="center" |'''Suggested management'''
| align="center" |'''Suggested management'''
Line 128: Line 125:
| rowspan="2" |No culture or antibiotic is required
| rowspan="2" |No culture or antibiotic is required
|-
|-
| align="left" |Absence of cough
| align="left" |Absence of [[cough]]
|align="center" | +1
|align="center" | +1
|align="center" |1
|align="center" |1
|align="center" |4-6%
|align="center" |4-6%
|-
|-
| align="left" |Swollen and tender anterior cervical nodes
| align="left" |[[Swollen]] and [[tender]] anterior [[cervical]] [[nodes]]
|align="center" | +1
|align="center" | +1
|align="center" |2
|align="center" |2
|align="center" |10-12%
|align="center" |10-12%
| rowspan="2" |RADT or Culture and treat only if culture result is positive
| rowspan="2" |[[RADT]] or Culture and treat only if culture result is positive
|-
|-
| align="left" |Tonsillar swelling or exudates
| align="left" |[[Tonsillar]] [[swelling]] or [[exudates]]
|align="center" | +1
|align="center" | +1
|align="center" |3
|align="center" |3
Line 159: Line 156:


=== Laboratory Findings ===
=== Laboratory Findings ===
There is a broad overlap between the signs and symptoms of [[streptococcal]] and non-streptococcal (usually viral) [[pharyngitis]], and the ability to identify streptococcal pharyngitis accurately on the basis of clinical grounds alone is generally poor.<ref name="pmid5056872">Wannamaker LW (1972) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=5056872 Perplexity and precision in the diagnosis of [[streptococcal]] pharyngitis.] ''Am J Dis Child'' 124 (3):352-8. PMID: [https://pubmed.gov/5056872 5056872]</ref><ref name="pmid855837">Breese BB (1977) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=855837 A simple scorecard for the tentative diagnosis of streptococcal pharyngitis.] ''Am J Dis Child'' 131 (5):514-7. PMID: [https://pubmed.gov/855837 855837]</ref><ref name="pmid15069046">McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE (2004) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=15069046 Empirical validation of guidelines for the management of pharyngitis in children and adults.] ''JAMA'' 291 (13):1587-95. [http://dx.doi.org/10.1001/jama.291.13.1587 DOI:10.1001/jama.291.13.1587] PMID: [https://pubmed.gov/15069046 15069046]</ref> Therefore, except when obvious viral clinical and epidemiological features are present, a laboratory test should be performed to determine whether [[Group A streptococcal infection|GAS]] is present in the pharynx.<ref name="pmid8637780">Bisno AL (1996) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=8637780 Acute pharyngitis: etiology and diagnosis.] ''Pediatrics'' 97 (6 Pt 2):949-54. PMID: [https://pubmed.gov/8637780 8637780]</ref><ref name="pmid15069046">McIsaac WJ, Kellner JD, Aufricht P, Vanjaka A, Low DE (2004) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=15069046 Empirical validation of guidelines for the management of pharyngitis in children and adults.] ''JAMA'' 291 (13):1587-95. [http://dx.doi.org/10.1001/jama.291.13.1587 DOI:10.1001/jama.291.13.1587] PMID: [https://pubmed.gov/15069046 15069046]</ref> Even subjects with all clinical features in a particular scoring system can be confirmed to have streptococcal pharyngitis only about 35%–50% of the time and this is particularly the case in children.<ref name="pmid855837">Breese BB (1977) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=855837 A simple scorecard for the tentative diagnosis of streptococcal pharyngitis.] ''Am J Dis Child'' 131 (5):514-7. PMID: [https://pubmed.gov/855837 855837]</ref> Swabbing the throat and testing for [[GAS]] pharyngitis with rapid antigen detection test (RADT)&/ culture should be performed because the clinical features alone do not reliably discriminate between [[GAS]] and [[viral]] pharyngitis except when overt viral features like [[rhinorrhea]], [[cough]], oral [[ulcers]], and/or hoarseness are present.
There is a broad overlap between the signs and symptoms of [[streptococcal]] and non-streptococcal (usually viral) [[pharyngitis]], and the ability to identify streptococcal pharyngitis accurately on the basis of clinical grounds alone is generally poor. Therefore, except when obvious viral clinical and epidemiological features are present, a laboratory test should be performed to determine whether [[Group A streptococcal infection|GAS]] is present in the pharynx. Even subjects with all clinical features in a particular scoring system can be confirmed to have streptococcal pharyngitis only about 35%–50% of the time and this is particularly the case in children. Swabbing the throat and testing for [[GAS]] pharyngitis with rapid antigen detection test ([[RADT]])&/ culture should be performed because the clinical features alone do not reliably discriminate between [[GAS]] and [[viral]] pharyngitis except when overt viral features like [[rhinorrhea]], [[cough]], oral [[ulcers]], and/or hoarseness are present.
* The rapid streptococcal antigen tests are widely available and have been used and studied extensively as an adjunct to making the diagnosis of [[Group A streptococcal|GAS]] pharyngitis. [[Specificity]] for the test has been reported to be as high as 95%, with a [[sensitivity]] of 80% to 90%. Throat cultures are much more sensitive, between 90% and 95%. However, they require up to 48 hours for results.<ref name="pmid23601485">Cirilli AR (2013) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=23601485 Emergency evaluation and management of the sore throat.] ''Emerg Med Clin North Am'' 31 (2):501-15. [http://dx.doi.org/10.1016/j.emc.2013.01.002 DOI:10.1016/j.emc.2013.01.002] PMID: [https://pubmed.gov/23601485 23601485]</ref>
* The rapid streptococcal antigen tests are widely available and have been used and studied extensively as an adjunct to making the diagnosis of [[Group A streptococcal|GAS]] pharyngitis. [[Specificity]] for the test has been reported to be as high as 95%, with a [[sensitivity]] of 80% to 90%. Throat cultures are much more sensitive, between 90% and 95%. However, they require up to 48 hours for results.
* A test negative for [[Group A streptococcal|GAS]] provides reassurance that the patient likely has a [[viral]] cause of [[pharyngitis]]. A negative test result also allows the clinician to safely avoid the use of antibiotics. Because of the general increase in rates of resistance to antibiotics, [[antimicrobial]] therapy should be prescribed only for proven episodes of [[ GAS]] pharyngitis.


* A test negative for [[Group A streptococcal|GAS]] provides reassurance that the patient likely has a [[viral]] cause of [[pharyngitis]]. A negative test result also allows the clinician to safely avoid the use of antibiotics. Because of the general increase in rates of resistance to antibiotics, [[antimicrobial]] therapy should be prescribed only for proven episodes of [[ GAS]] pharyngitis.<ref name="pmid12087516">Bisno AL, Gerber MA, Gwaltney JM, Kaplan EL, Schwartz RH, Infectious Diseases Society of America (2002) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=12087516 Practice guidelines for the diagnosis and management of group A [[streptococcal]] pharyngitis. Infectious Diseases Society of America.] ''Clin Infect Dis'' 35 (2):113-25. [http://dx.doi.org/10.1086/340949 DOI:10.1086/340949] PMID: [https://pubmed.gov/12087516 12087516]</ref><ref name="pmid11255529">Snow V, Mottur-Pilson C, Cooper RJ, Hoffman JR, American Academy of Family Physicians. American College of Physicians-American Society of Internal Medicine et al. (2001) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11255529 Principles of appropriate antibiotic use for acute pharyngitis in adults.] ''Ann Intern Med'' 134 (6):506-8. PMID: [https://pubmed.gov/11255529 11255529]</ref>
=== Special Considerations in the Diagnosis of Acute Pharyngitis in Adults ===
[[Group A streptococcal infection|GAS]] causes only 5%–15% of cases of acute pharyngitis in adults. The risk of [[acute pharyngitis]] due to GAS among adults is higher for parents of school-age children and for those whose occupation brings them into close association with children. However, the risk of a first attack of [[ARF]] is extremely low in adults, even with an undiagnosed and untreated episode of [[streptococcal pharyngitis]]. Because of these epidemiological distinctions, the use of a clinical algorithm without microbiological confirmation has been suggested as an acceptable alternative basis for the diagnosis of infection in adults. However, use of this diagnostic strategy would result in treatment of an unacceptably large number of adults with [[non-streptococcal]] [[pharyngitis]], which is an undesirable result in this age group, which has a low prevalence of [[GAS]] [[pharyngiti]]s and a very low risk of [[rheumatic fever]] or [[Rheumatic heart disease|rheumatic carditis]]. However, routine use of backup throat cultures for those with a negative [[RADT]] is not necessary for adults in usual circumstances, because of the low incidence of GAS pharyngitis in adults and because the risk of subsequent acute rheumatic fever is generally exceptionally low in adults with [[acute pharyngitis]].


=== Special Considerations in the Diagnosis of Acute Pharyngitis in Adults ===
[[Group A streptococcal infection|GAS]] causes only 5%–15% of cases of acute pharyngitis in adults.<ref name="pmid8637780">Bisno AL (1996) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=8637780 Acute pharyngitis: etiology and diagnosis.] ''Pediatrics'' 97 (6 Pt 2):949-54. PMID: [https://pubmed.gov/8637780 8637780]</ref> The risk of acute pharyngitis due to GAS among adults is higher for parents of school-age children and for those whose occupation brings them into close association with children. However, the risk of a first attack of [[ARF]] is extremely low in adults, even with an undiagnosed and untreated episode of streptococcal pharyngitis. Because of these epidemiological distinctions, the use of a clinical algorithm without microbiological confirmation has been suggested as an acceptable alternative basis for the diagnosis of infection in adults.<ref name="pmid11255529">Snow V, Mottur-Pilson C, Cooper RJ, Hoffman JR, American Academy of Family Physicians. American College of Physicians-American Society of Internal Medicine et al. (2001) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11255529 Principles of appropriate antibiotic use for acute pharyngitis in adults.] ''Ann Intern Med'' 134 (6):506-8. PMID: [https://pubmed.gov/11255529 11255529]</ref><ref name="pmid16567603">Humair JP, Revaz SA, Bovier P, Stalder H (2006) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=16567603 Management of acute pharyngitis in adults: reliability of rapid streptococcal tests and clinical findings.] ''Arch Intern Med'' 166 (6):640-4. [http://dx.doi.org/10.1001/archinte.166.6.640 DOI:10.1001/archinte.166.6.640] PMID: [https://pubmed.gov/16567603 16567603]</ref> However, use of this diagnostic strategy would result in treatment of an unacceptably large number of adults with non-streptococcal pharyngitis, which is an undesirable result in this age group, which has a low prevalence of GAS pharyngitis and a very low risk of [[rheumatic fever]] or [[Rheumatic heart disease|rheumatic carditis]]. However, routine use of backup throat cultures for those with a negative RADT is not necessary for adults in usual circumstances, because of the low incidence of GAS pharyngitis in adults and because the risk of subsequent acute rheumatic fever is generally exceptionally low in adults with acute pharyngitis.<ref name="pmid11255529">Snow V, Mottur-Pilson C, Cooper RJ, Hoffman JR, American Academy of Family Physicians. American College of Physicians-American Society of Internal Medicine et al. (2001) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=11255529 Principles of appropriate antibiotic use for acute pharyngitis in adults.] ''Ann Intern Med'' 134 (6):506-8. PMID: [https://pubmed.gov/11255529 11255529]</ref>
===Special Considerations in the Diagnosis of Acute Pharyngitis in Children <3 Years ===
===Special Considerations in the Diagnosis of Acute Pharyngitis in Children <3 Years ===
The prevalence of [[GAS]] pharyngitis is significantly lower for children <3 years of age, ranging from 10% to 14%, and if a corresponding rise in [[Antistreptococcal antibodies|Antistreptococcal-O antibody]] (ASO) is required, the prevalence can be as low as 0%– 6%.<ref name="pmid10378093">Nussinovitch M, Finkelstein Y, Amir J, Varsano I (1999) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=10378093 Group A beta-hemolytic streptococcal pharyngitis in preschool children aged 3 months to 5 years.] ''Clin Pediatr (Phila)'' 38 (6):357-60. PMID: [https://pubmed.gov/10378093 10378093]</ref><ref name="pmid8045744">Amir J, Shechter Y, Eilam N, Varsano I (1994) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=8045744 Group A beta-hemolytic streptococcal pharyngitis in children younger than 5 years.] ''Isr J Med Sci'' 30 (8):619-22. PMID: [https://pubmed.gov/8045744 8045744]</ref> Thus, diagnostic testing for GAS pharyngitis is not routinely indicated in children <3 years of age. However, if a child is <3 years of age and there is household contact with a school-aged sibling with documented streptococcal pharyngitis, then it is reasonable to consider testing the child if the child is symptomatic. Therefore, if a child is in daycare or another setting with a high rate of cases of [[Group A streptococcal|GAS]] infections, then it is reasonable to test symptomatic children and treat them if they are found to be positive for GAS.
The prevalence of [[GAS]] pharyngitis is significantly lower for children <3 years of age, ranging from 10% to 14%, and if a corresponding rise in [[Antistreptococcal antibodies|Antistreptococcal-O antibody]] (ASO) is required, the prevalence can be as low as 0%– 6%. Thus, diagnostic testing for [[GAS]] pharyngitis is not routinely indicated in children <3 years of age. However, if a child is <3 years of age and there is household contact with a school-aged sibling with documented [[streptococcal pharyngitis]], then it is reasonable to consider testing the child if the child is symptomatic. Therefore, if a child is in daycare or another setting with a high rate of cases of [[Group A streptococcal|GAS]] infections, then it is reasonable to test symptomatic children and treat them if they are found to be positive for [[GAS]].


===Algorithm for evaluation of acute pharyngitis===
===Algorithm for evaluation of acute pharyngitis===
The major goal of the evaluation of patients with [[sore throat]] or acute pharyngitis is to exclude potentially dangerous causes (e.g. [[Group A streptococcus]]), to identify any treatable causes, and to improve symptoms. Identifying [[group A streptococcus]] (GAS) is important because timely treatment with antibiotics helps prevent post-streptococcal complications such as [[acute rheumatic fever]].<ref name="pmid17054126">Del Mar CB, Glasziou PP, Spinks AB (2006) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=17054126 Antibiotics for sore throat.] ''Cochrane Database Syst Rev''  (4):CD000023. [http://dx.doi.org/10.1002/14651858.CD000023.pub3 DOI:10.1002/14651858.CD000023.pub3] PMID: [https://pubmed.gov/17054126 17054126]</ref> The evaluation includes a thorough history, focused physical examination, and diagnostic testing in selected patients.
The major goal of the evaluation of patients with [[sore throat]] or [[acute pharyngitis]] is to exclude potentially dangerous causes (e.g. [[Group A streptococcus]]), to identify any treatable causes, and to improve symptoms. Identifying [[group A streptococcus]] (GAS) is important because timely treatment with antibiotics helps prevent post-streptococcal complications such as [[acute rheumatic fever]]. The evaluation includes a thorough history, focused physical examination, and diagnostic testing in selected patients.


[[Image:Evaluation of acute pharyngitis.jpg|1000px]]
[[Image:Evaluation of acute pharyngitis.jpg|1000px]]


== Treatment ==
== Treatment ==
As is evident from potential etiologic agents of pharyngitis, [[group A streptococcus]] is the only commonly occurring form of acute pharyngitis for which antibiotic therapy is definitely indicated. Therefore, for a patient with acute pharyngitis, the clinical decision that usually needs to be made is whether or not the pharyngitis is attributable to GAS.<ref name="pmid23091044">Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G et al. (2012) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=23091044 Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America.] ''Clin Infect Dis'' 55 (10):1279-82. [http://dx.doi.org/10.1093/cid/cis847 DOI:10.1093/cid/cis847] PMID: [https://pubmed.gov/23091044 23091044]</ref>
As is evident from potential etiologic agents of [[pharyngitis]], [[group A streptococcus]] is the only commonly occurring form of [[acute pharyngitis]] for which antibiotic therapy is definitely indicated. Therefore, for a patient with [[acute pharyngitis]], the clinical decision that usually needs to be made is whether or not the pharyngitis is attributable to [[GAS]].
=== Medical Therapy ===
=== Medical Therapy ===
Patients with acute GAS pharyngitis should be treated with an appropriate antibiotic at an appropriate dose for a duration likely to eradicate the organism from the pharynx (usually 10 days). Based on their narrow spectrum of activity, in frequency of adverse reactions, and modest cost, [[penicillin]] or [[amoxicillin]] is the recommended drug of choice for those non-allergic to these agents.<ref name="pmid23091044">Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G et al. (2012) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=23091044 Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America.] ''Clin Infect Dis'' 55 (10):1279-82. [http://dx.doi.org/10.1093/cid/cis847 DOI:10.1093/cid/cis847] PMID: [https://pubmed.gov/23091044 23091044]</ref> Treatment of GAS pharyngitis in penicillin-allergic individuals should include a [[Cephalosporin|first generation cephalosporin]] (for those not anaphylactically sensitive) for 10 days, [[clindamycin]] or [[clarithromycin]] for 10 days, or [[azithromycin]] for 5 days. Adjunctive therapy with [[nonsteroidal anti-inflammatory drugs]] (NSAIDs), [[acetaminophen]], [[aspirin]], or [[Corticosteroid|corticosteroids]] may be useful in the management of GAS pharyngitis.
Patients with [[acute GAS pharyngitis]] should be treated with an appropriate antibiotic at an appropriate dose for a duration likely to eradicate the organism from the pharynx (usually 10 days). Based on their narrow spectrum of activity, the frequency of adverse reactions, and modest cost, [[penicillin]] or [[amoxicillin]] is the recommended drug of choice for those non-allergic to these agents. Treatment of GAS pharyngitis in penicillin-allergic individuals should include a [[Cephalosporin|first generation cephalosporin]] (for those not anaphylactically sensitive) for 10 days, [[clindamycin]] or [[clarithromycin]] for 10 days, or [[azithromycin]] for 5 days. Adjunctive therapy with [[nonsteroidal anti-inflammatory drugs]] (NSAIDs), [[acetaminophen]], [[aspirin]], or [[Corticosteroid|corticosteroids]] may be useful in the management of GAS pharyngitis.


=== Surgery ===
=== Surgery ===
[[Tonsillectomy]] may be an option for patients with recurrent streptococcal infections.<ref name="pmid22944886">Kociolek LK, Shulman ST (2012) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=22944886 In the clinic. Pharyngitis.] ''Ann Intern Med'' 157 (5):ITC3-1 - ITC3-16. [http://dx.doi.org/10.7326/0003-4819-157-5-20120904-01003 DOI:10.7326/0003-4819-157-5-20120904-01003] PMID: [https://pubmed.gov/22944886 22944886]</ref>
[[Tonsillectomy]] may be an option for patients with recurrent [[streptococcal]] infections.


=== Prevention ===
=== Prevention ===
Accurate diagnosis of streptococcal pharyngitis followed by appropriate antimicrobial therapy is important for the prevention of [[acute rheumatic fever]] and for the prevention of suppurative complications such as [[peritonsillar abscess]], [[Lymphadenitis|cervical lymphadenitis]], [[mastoiditis]].<ref name="pmid23091044">Shulman ST, Bisno AL, Clegg HW, Gerber MA, Kaplan EL, Lee G et al. (2012) [https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&retmode=ref&cmd=prlinks&id=23091044 Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America.] ''Clin Infect Dis'' 55 (10):1279-82. [http://dx.doi.org/10.1093/cid/cis847 DOI:10.1093/cid/cis847] PMID: [https://pubmed.gov/23091044 23091044]</ref>
Accurate diagnosis of [[streptococcal pharyngitis]] followed by appropriate [[antimicrobial]] therapy is important for the prevention of [[acute rheumatic fever]] and for the prevention of suppurative complications such as [[peritonsillar abscess]], [[Lymphadenitis|cervical lymphadenitis]], [[mastoiditis]].


==References==
==References==

Latest revision as of 18:57, 25 December 2020

Pharyngitis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Pharyngitis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

Ultrasound

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Pharyngitis overview On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Pharyngitis overview

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Pharyngitis overview

CDC on Pharyngitis overview

Pharyngitis overview in the news

Blogs on Pharyngitis overview

Directions to Hospitals Treating Type page name here

Risk calculators and risk factors for Pharyngitis overview

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Venkata Sivakrishna Kumar Pulivarthi M.B.B.S [2]Delband Yekta Moazami, M.D.[3]

Synonyms and keywords: Sore throat; Group A streptococcal pharyngitis; Bacterial pharyngitis; Viral pharyngitis; Acute pharyngitis; Chronic pharyngitis

Overview

A triad of sore throat, fever, and pharyngeal inflammation marked by erythema and edema are usually described as acute pharyngitis, although exudates, vesicles, or ulcerations may also be present. The inflammation of the pharynx, which presents as a sore throat, is pharyngitis. It is a painful inflammation of the pharynx and is colloquially referred to as a sore throat. Pharyngitis is a common medical problem in the outpatient medical setting, resulting in more than seven million pediatric visits each year. Most types of pharyngitis are caused by infectious etiologies. The most common cause of pharyngitis is a viral infection. However, some of the more serious types of pharyngitis are attributed to bacterial etiologies, such as group A-hemolytic Streptococcus pyogenes (GAS). Complications from GAS pharyngitis include rheumatic fever, deep space abscesses, and toxic shock. Although most episodes of pharyngitis are acute in nature, a small percentage becomes recurrent or chronic. With regards to chronic pharyngitis, non-infectious etiologies, such as Laryngopharyngeal reflux disease and periodic fever, aphthous ulcers, pharyngitis, and adenitis syndrome also need to be considered. Both medical and surgical therapies are effective in managing pharyngitis. Antibiotic treatment requires first-line medical therapy. Surgical management via adenotonsillectomy is recommended for certain indications. Adenotonsillectomy has been shown to be effective in reducing the burden of disease and improving the global quality of life and disease-specific. Several procedures, including traditional and intracapsular tonsillectomies, exist for adenotonsillectomy.

Historical Perspective

The sore throat was first described in the literature as 'some variants of sore throat' in the year 1879 by R. L. Bowles, M.D., in the British Medical Journal. Later, in 1885, David Newman, M.D., described pathology, symptoms, and treatment of pharyngitis.In 1910, the importance of bacteriological tests was shown in doubtful cases of pharyngitis. In 1931, three case reports were described and inferred that chronic non-tuberculous bronchial disease such as influenza, whooping cough, and measles is associated with chronic nasopharyngitis and also described the importance of conservative treatment in chronic nasopharyngitis.

Pathophysiology

The pathogenesis of the sore throat due to pharyngitis is poorly understood. The pharynx is often the first site of infection for many contagious diseases such as pharyngitis because pathogens such as viruses and bacteria often settle in the nasopharynx though inhalation or through droplets. Viral pharyngitis usually transmit from person to person through direct touch or through droplets transmission. The foreign invader reproduces rapidly after settling on the nasopharynx. Generally pharyngitis is a primary disease, but may be associated with systemic disorders such as the acute retroviral syndrome, or part of a more generalized upper respiratory tract infection.

Causes

Pharyngitis can be caused by infectious microorganisms or non-infectious agents. It is usually caused by viruses but may be caused by bacterial or fungal etiology. Gastroesophageal reflux disease (GERD) or particularly extra esophageal reflux (EER) can also cause an acid pharyngitis in adults and children.

Classification

Pharyngitis can be classified based on the duration as acute pharyngitis or chronic pharyngitis.

Differential Diagnosis

The major goal of the differentiating patients with sore throat or acute pharyngitis is to exclude potentially dangerous causes (e.g. Group A streptococcus), to identify any treatable causes, and to improve symptoms. Identifying the treatable causes is important because timely treatment with antibiotics helps prevent complications such as acute rheumatic fever, post streptococcal glomerulonephritis. Pharyngitis should be differentiated from other infectious causes which mimic sore throat that includes oral thrush, infectious mononucleosis, epiglottitis and peritonsillar abscess.

Epidemiology and Demographics

With more than 10 million outpatient visits per year, pharyngitis is one of the most common disorders in adults and children. Viruses are the single most common cause of pharyngitis and account for 25 percent to 45 percent of all cases. Group A streptococcus presents in up to 37% of all children presenting with a sore throat to an outpatient clinic or ED and 24% of those presenting at younger than 5 years. Group A streptococcus is by far the most common bacterial cause of acute pharyngitis, accounting for approximately 15 to 30 percent of cases in children and 5 to 10 percent of cases in adults. Peak seasons for sore throat include late winter and early spring.

Risk Factors

Pharyngitis is contagious, so anyone in close proximity to someone with the illness, is at risk. Social situations with prolonged close interpersonal contact are associated with a higher incidence of the disease, such as in schools, dormitories, or military barracks. Other common risk factors include a History of ill contact, Overcrowding, Frequent sinus infections, Smoking, attending daycare, immunocompromised patients, etc.

Natural History, Complications & Prognosis

Acute pharyngitis is typically described as the triad of sore throat, fever, and pharyngeal inflammation characterized by erythema and edema, although exudates, vesicles, or ulcerations may also be present. Although pharyngitis may be a primary disorder, sore throat and pharyngeal erythema may also be prominent in systemic disorders, such as the acute retroviral syndrome, or part of a more generalized upper respiratory tract infection. Most cases of acute pharyngitis are due to common viral infections and are benign, self-limited processes. The appropriate recognition of patients with more complicated infections that require diagnostic evaluations and treatment is one of the challenges of primary care medicine. An estimated 1-2% of acute pharyngitis progresses to recurrent or chronic disease.

Diagnosis

Key points in the evaluation of acute pharyngitis

  • Essential to diagnosis is the identification of treatable causes (e.g. Group A streptococcus) to prevent complications.
  • Testing for GAS pharyngitis should not be pursued in those with signs and symptoms indicative of a viral etiology.
  • Rapid antigen detection tests (RADTs) alone are sufficient for the diagnosis of GAS in adults, but negative results should be backed up by throat culture in children.
  • Specific techniques should be used to identify other causes where appropriate.
Guidelines Comparison for the Management of Acute Pharyngitis
Recommendation American College of Physicians (ACP) Infectious Diseases Society of America (IDSA)
Screening for acute pharyngitis Use Centor criteria Use clinical and epidemiologic findings to assess patient’s risk of GABHS (e.g., sudden onset of sore throat, fever, odynophagia, tonsillar erythema, exudates, cervical lymphadenitis, or history of streptococcal exposure)
Diagnostic testing RADT with Centor score of 2 or 3 only RADT or throat culture in all patients at risk
Back-up culture needed if RADT results negative? Adults: No

Children: Yes

Adults: No

Children: Yes

Who requires antibiotic treatment? Empiric antibiotics for Centor score of 3 or 4; treat patients with positive RADT result Positive RADT result or throat culture
Antibiotic of choice Oral penicillin V (Veetids; brand no longer available in the United States); intramuscular penicillin G benzathine (Bicillin L-A); oral amoxicillin with equal effectiveness and better palatability in children
Penicillin allergy Oral erythromycin; cephalosporin (first generation)

History and Symptoms

Pharyngitis is a very common inflammatory condition of the pharynx accompanied by a sore throat and occasionally difficulty in swallowing. Other symptoms depends on the etiology such as bacterial or viral.

Clinical features of acute pharyngitis
Group A streptococcal pharyngitis Viral pharyngitis

Physical Examination

Patients with pharyngitis typically have low-grade fever and pharyngeal erythema, suggestive of viral etiology or pharyngeal exudate or petechia, suggestive of GAS. Additional signs include enlarged edematous tonsils, enlarged and/or tender cervical adenopathy, the rash that may or may not be present. Scarlatiniform rash, which is marked by multiple small red papules that are widely and diffusely distributed but spare the palms and soles, is suggestive of GAS.

Centor criteria
The original Center score uses four signs and symptoms to estimate the probability of acute streptococcal pharyngitis in adults with a sore throat The score was later modified by adding age. It is important to evaluate for a definitive diagnosis to exclude GAS and to avoid unnecessary lab tests and antibiotic use. Centor criteria are a widely used and accepted clinical decision tool in identifying patients for whom neither microbiologic tests nor antimicrobial therapy is necessary. The Center score to use for children and adults with a sore throat to estimate the probability of Streptococcus pyogenes infection.

Modified Centor criteria Appropriate management according to the total score
Criteria Points Total score Chance of streptococcal infection in community

with usual levels of infection, %

Suggested management
Fever (temperature > 38°C) +1 0 2-3% No culture or antibiotic is required
Absence of cough +1 1 4-6%
Swollen and tender anterior cervical nodes +1 2 10-12% RADT or Culture and treat only if culture result is positive
Tonsillar swelling or exudates +1 3 27-28%
Age 3–14 yr +1 4 38–63% Culture all and treat emperically with penicillin on clinical grounds
Age 15–44 yr 0
Age ≥ 45 yr -1

Laboratory Findings

There is a broad overlap between the signs and symptoms of streptococcal and non-streptococcal (usually viral) pharyngitis, and the ability to identify streptococcal pharyngitis accurately on the basis of clinical grounds alone is generally poor. Therefore, except when obvious viral clinical and epidemiological features are present, a laboratory test should be performed to determine whether GAS is present in the pharynx. Even subjects with all clinical features in a particular scoring system can be confirmed to have streptococcal pharyngitis only about 35%–50% of the time and this is particularly the case in children. Swabbing the throat and testing for GAS pharyngitis with rapid antigen detection test (RADT)&/ culture should be performed because the clinical features alone do not reliably discriminate between GAS and viral pharyngitis except when overt viral features like rhinorrhea, cough, oral ulcers, and/or hoarseness are present.

  • The rapid streptococcal antigen tests are widely available and have been used and studied extensively as an adjunct to making the diagnosis of GAS pharyngitis. Specificity for the test has been reported to be as high as 95%, with a sensitivity of 80% to 90%. Throat cultures are much more sensitive, between 90% and 95%. However, they require up to 48 hours for results.
  • A test negative for GAS provides reassurance that the patient likely has a viral cause of pharyngitis. A negative test result also allows the clinician to safely avoid the use of antibiotics. Because of the general increase in rates of resistance to antibiotics, antimicrobial therapy should be prescribed only for proven episodes of GAS pharyngitis.

Special Considerations in the Diagnosis of Acute Pharyngitis in Adults

GAS causes only 5%–15% of cases of acute pharyngitis in adults. The risk of acute pharyngitis due to GAS among adults is higher for parents of school-age children and for those whose occupation brings them into close association with children. However, the risk of a first attack of ARF is extremely low in adults, even with an undiagnosed and untreated episode of streptococcal pharyngitis. Because of these epidemiological distinctions, the use of a clinical algorithm without microbiological confirmation has been suggested as an acceptable alternative basis for the diagnosis of infection in adults. However, use of this diagnostic strategy would result in treatment of an unacceptably large number of adults with non-streptococcal pharyngitis, which is an undesirable result in this age group, which has a low prevalence of GAS pharyngitis and a very low risk of rheumatic fever or rheumatic carditis. However, routine use of backup throat cultures for those with a negative RADT is not necessary for adults in usual circumstances, because of the low incidence of GAS pharyngitis in adults and because the risk of subsequent acute rheumatic fever is generally exceptionally low in adults with acute pharyngitis.

Special Considerations in the Diagnosis of Acute Pharyngitis in Children <3 Years

The prevalence of GAS pharyngitis is significantly lower for children <3 years of age, ranging from 10% to 14%, and if a corresponding rise in Antistreptococcal-O antibody (ASO) is required, the prevalence can be as low as 0%– 6%. Thus, diagnostic testing for GAS pharyngitis is not routinely indicated in children <3 years of age. However, if a child is <3 years of age and there is household contact with a school-aged sibling with documented streptococcal pharyngitis, then it is reasonable to consider testing the child if the child is symptomatic. Therefore, if a child is in daycare or another setting with a high rate of cases of GAS infections, then it is reasonable to test symptomatic children and treat them if they are found to be positive for GAS.

Algorithm for evaluation of acute pharyngitis

The major goal of the evaluation of patients with sore throat or acute pharyngitis is to exclude potentially dangerous causes (e.g. Group A streptococcus), to identify any treatable causes, and to improve symptoms. Identifying group A streptococcus (GAS) is important because timely treatment with antibiotics helps prevent post-streptococcal complications such as acute rheumatic fever. The evaluation includes a thorough history, focused physical examination, and diagnostic testing in selected patients.

Treatment

As is evident from potential etiologic agents of pharyngitis, group A streptococcus is the only commonly occurring form of acute pharyngitis for which antibiotic therapy is definitely indicated. Therefore, for a patient with acute pharyngitis, the clinical decision that usually needs to be made is whether or not the pharyngitis is attributable to GAS.

Medical Therapy

Patients with acute GAS pharyngitis should be treated with an appropriate antibiotic at an appropriate dose for a duration likely to eradicate the organism from the pharynx (usually 10 days). Based on their narrow spectrum of activity, the frequency of adverse reactions, and modest cost, penicillin or amoxicillin is the recommended drug of choice for those non-allergic to these agents. Treatment of GAS pharyngitis in penicillin-allergic individuals should include a first generation cephalosporin (for those not anaphylactically sensitive) for 10 days, clindamycin or clarithromycin for 10 days, or azithromycin for 5 days. Adjunctive therapy with nonsteroidal anti-inflammatory drugs (NSAIDs), acetaminophen, aspirin, or corticosteroids may be useful in the management of GAS pharyngitis.

Surgery

Tonsillectomy may be an option for patients with recurrent streptococcal infections.

Prevention

Accurate diagnosis of streptococcal pharyngitis followed by appropriate antimicrobial therapy is important for the prevention of acute rheumatic fever and for the prevention of suppurative complications such as peritonsillar abscess, cervical lymphadenitis, mastoiditis.

References

Template:WH Template:WS